Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnaud Mejean

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
European Urology|February 13, 2023
Re: Ithaar H. Derweesh, Rana R. McKay, Aditya Bagrodia. Primary Cytoreductive Nephrectomy: Standing the Test of Time? Eur Urol. 2023;83:152-3Arnaud Mejean
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 19, 2007
[Surgery for locally advanced kidney cancer]Arnaud Mejean
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 5, 2002
[Metastatic kidney cancer: new therapeutic approaches]Sylvie Negrier, Arnaud Mejean, Stéphane Oudard, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 8, 2006
[Follow-up of renal cancer. Guidelines of the Comité de Cancérologie de l'Association Française d'Urologie]Jean-Philippe Fendler, Jean-Jacques Patard, Arnaud Mejean, et al.
The Journal of Urology|December 18, 2001
Nephron sparing surgery for renal cell carcinoma using selective renal parenchymal clampingArnaud Mejean, Benoit Vogt, Sebastien Cazin, et al.
The Canadian Journal of Urology|October 3, 2009
Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrenceNicolas B Delongchamps, Marc Zerbib, Arnaud Mejean, et al.
Investigational New Drugs|June 24, 2009
Sunitinib inducing tumor lysis syndrome in a patient treated for renal carcinomaJudith Michels, Nathalie Lassau, Marine Gross-Goupil, et al.
Expert Review of Anticancer Therapy|March 20, 2014
Prognostic factors in patients with advanced renal cell carcinoma treated with VEGF-targeted agentsYann-Alexandre Vano, Eric Tartour, Laure S Fournier, et al.
Urology|March 7, 2002
Coloepiploic mobilization during left radical nephrectomy for renal cell carcinoma is indicated to reduce the risk of iatrogenic splenectomyArnaud Mejean, Yves Chretien, Benoit Vogt, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 6, 2004
[Hereditary renal cell carcinoma: results and place of conventional conservative surgery]Morgan Roupret, Vincent Hupertan, Yves Chretien, et al.
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
European Urology|February 13, 2023
Re: Ithaar H. Derweesh, Rana R. McKay, Aditya Bagrodia. Primary Cytoreductive Nephrectomy: Standing the Test of Time? Eur Urol. 2023;83:152-3Arnaud Mejean
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 19, 2007
[Surgery for locally advanced kidney cancer]Arnaud Mejean
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 5, 2002
[Metastatic kidney cancer: new therapeutic approaches]Sylvie Negrier, Arnaud Mejean, Stéphane Oudard, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 8, 2006
[Follow-up of renal cancer. Guidelines of the Comité de Cancérologie de l'Association Française d'Urologie]Jean-Philippe Fendler, Jean-Jacques Patard, Arnaud Mejean, et al.
The Journal of Urology|December 18, 2001
Nephron sparing surgery for renal cell carcinoma using selective renal parenchymal clampingArnaud Mejean, Benoit Vogt, Sebastien Cazin, et al.
The Canadian Journal of Urology|October 3, 2009
Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrenceNicolas B Delongchamps, Marc Zerbib, Arnaud Mejean, et al.
Investigational New Drugs|June 24, 2009
Sunitinib inducing tumor lysis syndrome in a patient treated for renal carcinomaJudith Michels, Nathalie Lassau, Marine Gross-Goupil, et al.
Expert Review of Anticancer Therapy|March 20, 2014
Prognostic factors in patients with advanced renal cell carcinoma treated with VEGF-targeted agentsYann-Alexandre Vano, Eric Tartour, Laure S Fournier, et al.
Urology|March 7, 2002
Coloepiploic mobilization during left radical nephrectomy for renal cell carcinoma is indicated to reduce the risk of iatrogenic splenectomyArnaud Mejean, Yves Chretien, Benoit Vogt, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 6, 2004
[Hereditary renal cell carcinoma: results and place of conventional conservative surgery]Morgan Roupret, Vincent Hupertan, Yves Chretien, et al.
Pageof 10